在美国南部一个学术医疗中心接受治疗的非裔美国男性前列腺癌筛查的预测因素。

Current cancer reports Pub Date : 2021-06-15 Epub Date: 2021-04-02 DOI:10.25082/CCR.2021.01.003
Steven S Coughlin, Deepak Nag Ayyala, John S Luque, Justin Xavier Moore
{"title":"在美国南部一个学术医疗中心接受治疗的非裔美国男性前列腺癌筛查的预测因素。","authors":"Steven S Coughlin, Deepak Nag Ayyala, John S Luque, Justin Xavier Moore","doi":"10.25082/CCR.2021.01.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The controversy surrounding prostate cancer screening, coupled with the high rates of incidence and mortality among African American men, increase the importance of African American men engaging in an informed decision-making process around prostate cancer screening.</p><p><strong>Purpose: </strong>To examine predictors of prostate cancer screening via the prostate-specific antigen (PSA) test. Secondary objectives were to examine whether African American men have been screened for prostate cancer; their confidence in making an informed choice about whether PSA testing is right for them; and whether they have talked with their provider about PSA testing and engaged in an informed decision-making process around prostate cancer screening.</p><p><strong>Methods: </strong>We conducted a study among a sample of African American men patients ages ≥ 40 years.</p><p><strong>Results: </strong>A total of 65 men completed the questionnaire (response rate = 6.5%). The mean age of the men was 64.4 years. Most of the participants (90.8%) reported a regular healthcare provider and that their provider had discussed the PSA test with them (81.3%). About 84.1% of the men ever had a PSA test, but only 38.0% had one in the past year. Most of the men reported that they make the final decision about whether to have a PSA test on their own (36.5%) or after seriously considering their doctor's opinion (28.6%). About 31.8% of the men reported that they share responsibility about whether to have a PSA test with their doctor. About half of the participants (49.2%) reported that they have made a decision about whether to have a PSA test and they are not likely to change their mind. The majority of the men (75%) perceived their risk of prostate cancer to be about the same level of risk as other men who were their age. The men's knowledge of prostate cancer was fair to good (mean prostate cancer knowledge scale = 10.37, SD 1.87). Knowledge of prostate cancer was positively associated with receipt of a PSA test (p < 0.0206).</p><p><strong>Discussion: </strong>The modest overall prostate cancer knowledge among these participants, including their risk for prostate cancer, indicates a need for prostate cancer educational interventions in this patient population.</p>","PeriodicalId":72728,"journal":{"name":"Current cancer reports","volume":" ","pages":"81-94"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064558/pdf/","citationCount":"2","resultStr":"{\"title\":\"Predictors of prostate cancer screening among African American men treated at an Academic Medical Center in the Southern United States.\",\"authors\":\"Steven S Coughlin, Deepak Nag Ayyala, John S Luque, Justin Xavier Moore\",\"doi\":\"10.25082/CCR.2021.01.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The controversy surrounding prostate cancer screening, coupled with the high rates of incidence and mortality among African American men, increase the importance of African American men engaging in an informed decision-making process around prostate cancer screening.</p><p><strong>Purpose: </strong>To examine predictors of prostate cancer screening via the prostate-specific antigen (PSA) test. Secondary objectives were to examine whether African American men have been screened for prostate cancer; their confidence in making an informed choice about whether PSA testing is right for them; and whether they have talked with their provider about PSA testing and engaged in an informed decision-making process around prostate cancer screening.</p><p><strong>Methods: </strong>We conducted a study among a sample of African American men patients ages ≥ 40 years.</p><p><strong>Results: </strong>A total of 65 men completed the questionnaire (response rate = 6.5%). The mean age of the men was 64.4 years. Most of the participants (90.8%) reported a regular healthcare provider and that their provider had discussed the PSA test with them (81.3%). About 84.1% of the men ever had a PSA test, but only 38.0% had one in the past year. Most of the men reported that they make the final decision about whether to have a PSA test on their own (36.5%) or after seriously considering their doctor's opinion (28.6%). About 31.8% of the men reported that they share responsibility about whether to have a PSA test with their doctor. About half of the participants (49.2%) reported that they have made a decision about whether to have a PSA test and they are not likely to change their mind. The majority of the men (75%) perceived their risk of prostate cancer to be about the same level of risk as other men who were their age. The men's knowledge of prostate cancer was fair to good (mean prostate cancer knowledge scale = 10.37, SD 1.87). Knowledge of prostate cancer was positively associated with receipt of a PSA test (p < 0.0206).</p><p><strong>Discussion: </strong>The modest overall prostate cancer knowledge among these participants, including their risk for prostate cancer, indicates a need for prostate cancer educational interventions in this patient population.</p>\",\"PeriodicalId\":72728,\"journal\":{\"name\":\"Current cancer reports\",\"volume\":\" \",\"pages\":\"81-94\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064558/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current cancer reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25082/CCR.2021.01.003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/4/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25082/CCR.2021.01.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/4/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

背景:围绕前列腺癌筛查的争议,加上非裔美国男性的高发病率和死亡率,增加了非裔美国男性参与前列腺癌筛查知情决策过程的重要性。目的:探讨前列腺特异性抗原(PSA)检测对前列腺癌筛查的影响因素。次要目的是检查非裔美国男性是否接受过前列腺癌筛查;他们对PSA检测是否适合自己做出明智选择的信心;以及他们是否与医生讨论过PSA检测,是否参与了前列腺癌筛查的知情决策过程。方法:我们在年龄≥40岁的非裔美国男性患者中进行了一项研究。结果:共65名男性完成问卷调查,回复率为6.5%。男性的平均年龄为64.4岁。大多数参与者(90.8%)报告有固定的医疗保健提供者,并且他们的提供者与他们讨论过PSA测试(81.3%)。约84.1%的男性曾经做过PSA检测,但在过去一年中只有38.0%做过。大多数男性报告说,他们在自己(36.5%)或认真考虑医生意见后做出是否进行PSA检测的最终决定(28.6%)。约31.8%的男性报告说,他们与医生共同承担是否进行PSA检测的责任。大约一半的参与者(49.2%)报告说,他们已经决定是否进行PSA测试,他们不太可能改变主意。大多数男性(75%)认为他们患前列腺癌的风险与同龄男性大致相同。男性对前列腺癌的认知程度从一般到较好(平均前列腺癌知识量表= 10.37,SD = 1.87)。前列腺癌知识与接受PSA检测呈正相关(p < 0.0206)。讨论:这些参与者对前列腺癌的总体了解,包括他们患前列腺癌的风险,表明需要对这些患者群体进行前列腺癌教育干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Predictors of prostate cancer screening among African American men treated at an Academic Medical Center in the Southern United States.

Background: The controversy surrounding prostate cancer screening, coupled with the high rates of incidence and mortality among African American men, increase the importance of African American men engaging in an informed decision-making process around prostate cancer screening.

Purpose: To examine predictors of prostate cancer screening via the prostate-specific antigen (PSA) test. Secondary objectives were to examine whether African American men have been screened for prostate cancer; their confidence in making an informed choice about whether PSA testing is right for them; and whether they have talked with their provider about PSA testing and engaged in an informed decision-making process around prostate cancer screening.

Methods: We conducted a study among a sample of African American men patients ages ≥ 40 years.

Results: A total of 65 men completed the questionnaire (response rate = 6.5%). The mean age of the men was 64.4 years. Most of the participants (90.8%) reported a regular healthcare provider and that their provider had discussed the PSA test with them (81.3%). About 84.1% of the men ever had a PSA test, but only 38.0% had one in the past year. Most of the men reported that they make the final decision about whether to have a PSA test on their own (36.5%) or after seriously considering their doctor's opinion (28.6%). About 31.8% of the men reported that they share responsibility about whether to have a PSA test with their doctor. About half of the participants (49.2%) reported that they have made a decision about whether to have a PSA test and they are not likely to change their mind. The majority of the men (75%) perceived their risk of prostate cancer to be about the same level of risk as other men who were their age. The men's knowledge of prostate cancer was fair to good (mean prostate cancer knowledge scale = 10.37, SD 1.87). Knowledge of prostate cancer was positively associated with receipt of a PSA test (p < 0.0206).

Discussion: The modest overall prostate cancer knowledge among these participants, including their risk for prostate cancer, indicates a need for prostate cancer educational interventions in this patient population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nanotherapeutics to cure inflammation-induced cancer Breast carcinoma in the Democratic Republic of the Congo: Characterization of hormone receptors Perspectives on chemotherapy-induced toxicities in pancreatic cancer Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy Safety and feasibility of Preoperative Simultaneous Portal Vein Embolization and Biliary Drainage in Hilar Cholangiocarcinoma prior to Hepatectomy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1